Emcure Pharma Pune facility gets 2 USFDA observations Ruchika Sharma26 Feb 2025 3:14 PM ISTPune: Emcure Pharmaceuticals Limited has announced that the Company has received two observations in Form 483 from the United States Food and...
Indian Pharma Market reaches Rs 19,083 crore in December, Check out top performing brands Farhat Nasim16 Jan 2025 7:43 PM ISTNew Delhi: The Indian Pharmaceutical Market (IPM) has experienced robust growth, reaching a market value of Rs 19,083 crore in December 2024. This...
Indian Pharma Market registers 8 percent surge to Rs 17,937 Crore in January 2024: IQVIA Farhat Nasim19 Feb 2024 7:19 PM ISTNew Delhi: In an impressive kickoff to 2024, the Indian pharmaceutical market surged by 8%, reaching a substantial Rs 17,937 crore in January, as per...
Emcure Pharmaceuticals Ltd Launches Orofer FCM in 750 mg to Treat Iron Deficiency Anaemia for Patients in India Isra Zaman17 May 2023 4:46 PM ISTMumbai: One of the leaders in the gynaecology segment, Emcure Pharmaceuticals Ltd, has recently announced the launch of Orofer FCM 750, a new...
NPPA fixes ceiling price of Amphotericin B Emulsion Injection to treat Black Fungus Medical Dialogues Team11 July 2021 11:30 AM ISTNew Delhi: Through a recent Office Memorandum, the National Pharmaceutical Pricing Authority (NPPA) has confirmed the ceiling price of antifungal drug...
ABCD Technologies onboards 9 new investors including Glenmark, Alembic pharma Medical Dialogues Team5 May 2021 12:47 PM ISTNew Delhi: With the aim of building the IT infrastructure and supply chain required for pharmaceutical distribution, ABCD Technologies LLP (to be...
Emcure Secures CDSCO Committee nod for manufacturing, marketing of Metoprolol Telmisartan FDC MD Bureau16 Jan 2021 5:01 PM ISTNew Delhi: After reviewing the Bioequivalence (BE) study report of the fixed-dose combination (FDC) of Metoprolol Telmisartan, the Central Drugs...
CDSCO panel rejects Emcure Voglibose, Vildagliptin FDC citing dosage schedule incompatibility between ingredients Farhat Nasim25 Dec 2020 1:18 PM ISTNew Delhi: Citing dosage schedule incompatibility between the ingredients, the Subject Expert Committee (SEC) functional under the Central Drugs...
Allegations of Pharma Collusion for Fixing Price of Vidagliptin: Court dismisses Abbotts plea again CCI Probe Meghna A Singhania25 Nov 2018 8:18 PM ISTNew Delhi: Quashing the petition filed by leading drug maker Abbott, that wanted to stall the CCI probe into alleged carterlisation to fix the prices...
Banning Compulsory Purchase From Hospital In-House Pharmacies: SC notice To Centre, State Meghna A Singhania15 May 2018 1:09 PM ISTNew Delhi: Seeking a permanent ban on the policy of compulsory purchase form In House hospital pharmacies for patients admitted to the private...
Pharma Cos not under MCI, hence can claim deductions on promotion to doctors: IT Tribunal Meghna A Singhania3 March 2018 3:06 PM ISTMumbai: Through a recent judgement, the Income Tax Appellate Tribunal, Pune Bench has allowed a Pharmaceutical company to claim deductions on...
Emcure Pharmaceuticals faces ban from USFDA for Maharashtra plant Meghna A Singhania15 July 2015 11:40 AM ISTUS FDA bans Emcure Pharmaceuticals' Maharashtra plant over manufacturing issuesIndian pharmaceuticals industry is the largest supplier of medicines to...
